Instituto Do Cancer Do Estado De São Paulo
Clinical trials sponsored by Instituto Do Cancer Do Estado De São Paulo, explained in plain language.
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Blood test could revolutionize cancer monitoring in Brazil's public health system
Knowledge-focused Recruiting nowThis study is testing a new, low-cost blood test that looks for tumor DNA from HPV-related cancers (cervical and anal) after standard radiation treatment. The goal is to see if this simple test can replace expensive scans and biopsies for monitoring patients, and to identify thos…
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC